HitGen with Janssen to build novel DNA-Encoded Libraries

China |  News | 0 Comment | 10 Dec, 2019

China based HitGen Inc. is pleased to announce that the company has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson...Read more

AI biotech firm Zenerchi to penetrate within Asia

China |  News | 0 Comment | 09 Dec, 2019

Life extension and biomedical simulation and visualization AI company US based Zenerchi and China based Pop Life Global have entered into an agreement for development of...Read more

AstraZeneca receives Chinese marketing nod for Lynparza

China |  News | 0 Comment | 09 Dec, 2019

AstraZeneca and MSD have announced that the companies have received marketing authorisation from China’s National Medical Products Administration (NMPA) for Lynparza (o...Read more

Merck, Ping An Good Doctor to advance healthcare in China

China |  News | 0 Comment | 05 Dec, 2019

Merck, a leading science and technology company, has signed a strategic collaboration agreement with one of the world's leading healthcare ecosystem platforms, Ping An Healthcare and Techno...Read more

Brii Biosciences expands focus to neurosciences

China |  News | 0 Comment | 04 Dec, 2019

Brii Biosciences, a clinical-stage company committed to serving patients’ needs and improving public health in China and around the world, has announced two leadership appointments th...Read more

CASI Pharma gets China approval Of CNCT19 Clinical Trial Applications

China |  News | 0 Comment | 04 Dec, 2019

CASI Pharmaceuticals, Inc., a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, announces that the China National...Read more

China NMPA accepts Lenvima for Additional Indication of Thyroid Cancer

China |  News | 0 Comment | 04 Dec, 2019

Tokyo based Eisai Co., Ltd. has announced that LENVIMA (generic name: lenvatinib), the orally available kinase inhibitor discovered by Eisai, has been accepted by the National Medical Produ...Read more

CMAB, Fapon join hands for biologic oncology asset

China |  News | 0 Comment | 03 Dec, 2019

CMAB Biopharma Inc., a pure-play, biologics contract manufacturing and development organization (CDMO) and Shenzhen Fapon Biopharma Inc., an innovative biopharmaceutical company, announced ...Read more

ChainZ Medical integrates RADLogics™ Virtual Resident™ AI solution

China |  News | 0 Comment | 02 Dec, 2019

RADLogics™ has announced that the China-based ChainZ Medical Technology Co. has selected the RADLogics Virtual Resident™ AI solution to integrate with its Smart Cloud PACS/RIS s...Read more

Innovent, Eli Lilly presents co-developed cancer-fighting Tyvyt at CIIE 2019

China |  News | 0 Comment | 02 Dec, 2019

Innovent Biologics, a multinational biopharmaceutical company, and Eli Lilly and Company presented their co-developed Tyvyt® (generic name: sintilimab injection), a fully human anti-pro...Read more

Ascletis gets pharmaceutical trade license and GSP certificate

China |  News | 0 Comment | 02 Dec, 2019

Ascletis Pharma, an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseas...Read more

"Tencent Medipedia helps patients by providing trust worthy information"

China |  Opinion | 0 Comment | 29 Nov, 2019

Zhang Meng, Vice President, Tencent Medical, leads digital healthcare innovation incubation in Tencent. He has successfully led the team in Tencent Medical for developing a brand new public...Read more

Decoding healthcare with Tencent Medical

China |  News | By Milind kokje | 0 Comment | 29 Nov, 2019

“Tech for good” is the vision and mission of Tencent, which believes that progressive technology can help humans unlock the mysteries of life. “Our vision and mission gui...Read more

Genetron gets approval for semiconductor-based NGS System

China |  News | 0 Comment | 03 Dec, 2019

Genetron Health, a China-based precision oncology company that covers full-cycle cancer care, has obtained regulatory approval in China to launch its GENETRON S5 for clinical use. The appro...Read more

Chi-Med’s Elunate enters National Reimbursement Drug List

China |  News | 0 Comment | 02 Dec, 2019

Hutchison China MediTech Limited (Chi-Med) has announced that Elunate® (fruquintinib capsules), its national class 1 targeted anticancer drug for the treatment of patients with adv...Read more

Now Innovent and Lilly’s Tyvyt included in NRDL

China |  News | 0 Comment | 29 Nov, 2019

Innovent Biologics, Inc. ("Innovent") a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic an...Read more

Shamrock Biopharma closes 304 M yuan in Series B financing

China |  News | 0 Comment | 29 Nov, 2019

China based Shamrock Biopharmaceuticals, a global clinical stage, biopharmaceutical company committed to innovative and transformative biopharmaceutical research and development, has announ...Read more

IMCD opens 3 Pharma Technical Centres in Asia Pacific

China |  News | 0 Comment | 28 Nov, 2019

IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and food ingredients, has announces the expansion of its global network of Pharmaceuti...Read more